Role of cAMP in mediating AHR signaling

Biochemical Pharmacology

Volumn 77, Issue 4, 2009, Pages 627-641

  Oesch Bartlomowicz, Barbara ^a   Oesch, Franz ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Aryl hydrocarbon receptor; cyclic AMP; Dioxin toxicity; Nuclear translocation; Phosphorylation; Protein kinase A; Signal transduction

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CASEIN KINASE II; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP RECEPTOR; CYTOCHROME P450 1A1; DIOXIN; PROTEIN EPAC; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN TARGETING; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; XENOBIOTIC METABOLISM;

ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOCHROME P-450 CYP1A1; DIOXINS; ENVIRONMENTAL POLLUTANTS; HUMANS; LIGANDS; PROTEIN TRANSPORT; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 59149102150     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.10.017     Document Type: Review

References (156)

1. Hahn M.E. Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact 141 (2002) 131-160
2. Emmons R.B., Duncan D., Estes P.A., Kiefel P., Mosher J.T., Sonnenfeld M., et al. The spineless-aristapedia and tango bHLH-PAS proteins interact to control antennal and tarsal development in Drosophila. Development 126 (1999) 3937-3945
3. Wernet M.F., Mazzoni E.O., Celik A., Duncan D.M., Duncan I., and Desplan C. Stochastic spineless expression creates the retinal mosaic for colour vision. Nature 440 (2006) 174-180
4. Conney A.H., Miller E.C., and Miller J.A. Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J Biol Chem 228 (1957) 753-766
5. Poland A., Glover E., and Kende A.S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251 (1976) 4936-4946
6. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res 42 (1982) 4875-4917
7. 2 zinc finger protein Msn2p is regulated by stress and protein kinase A activity. Genes Dev 12 (1998) 586-597
8. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35 (1995) 307-340
9. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268 (1995) 722-726
10. Schmidt J.V., Su G.H., Reddy J.K., Simon M.C., and Bradfield C.A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93 (1996) 6731-6736
11. Lahvis G.P., Lindell S.L., Thomas R.S., McCuskey R.S., Murphy C., Glover E., et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci USA 97 (2000) 10442-10446
12. Denison M.S., and Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43 (2003) 309-334
13. Nguyen L.P., and Bradfield C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21 (2008) 102-116
14. Teruel M.N., and Meyer T. Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell 103 (2000) 181-184
15. Walsh D.A., and Van Patten S.M. Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB J 8 (1994) 1227-1236
16. Sutherland E.W. Studies on the mechanism of hormone action. Science 177 (1972) 401-408
17. Baker D.A., and Kelly J.M. Structure, function and evolution of microbial adenylyl and guanylyl cyclases. Mol Microbiol 52 (2004) 1229-1242
18. Jarnaess E., and Taskén K. Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans 35 (2007) 931-937
19. Barnes A.P., Livera G., Hunag P., Sun C., O'Neal W.K., Conti M., et al. Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium. J Biol Chem 280 (2005) 7997-8003
20. Buxton I.L., and Brunton L.L. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 258 (1983) 10233-10239
21. 2+ channels by beta-adrenergic agonists. Proc Natl Acad Sci USA 93 (1996) 295-299
22. Rich T.C., Fagan K.A., Tse T.E., Schaack J., Cooper D.M.F., and Karpen J.W. A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc Natl Acad Sci USA 98 (2001) 13049-13054
23. Zaccolo M., and Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295 (2002) 1711-1715
24. Hayes J.S., Brunton L.L., and Mayer S.E. Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1. J Biol Chem 255 (1980) 5113-5119
25. DiPilato L.M., Cheng X., and Zhang J. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci U S A 101 (2004) 16513-16518
26. Taylor S.S., Buechler J.A., and Yonemoto W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 59 (1990) 971-1005
27. Matulef K., and Zagotta W.N. Cyclic nucleotide-gated ion channels. Annu Rev Cell Dev Biol 19 (2003) 23-44
28. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature (1998) 396474-396477
29. Bos J.L. Epac: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol 4 September (9) (2003) 733-738
30. Beavo J.A., and Brunton L.L. Cyclic nucleotide research-still expanding after half a century. Nat Rev Mol Cell Biol 3 (2002) 710-718
31. O'Neill J.S., Maywood E.S., Chesham J.E., Takahashi J.S., and Hastings M.H. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 320 (2008) 879-880
32. Sands W.A., and Palmer T.M. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal 20 (2008) 460-466
33. Zaccolo M., Di Benedetto G., Lissandron V., Mancuso L., Terrin A., and Zamparo I. Restricted diffusion of a freely diffusible second messenger: mechanisms underlying compartmentalized cAMP signalling. Biochem Soc Trans 34 (2006) 495-497
34. Poellinger L. Mechanism of signal transduction by the basic helix-loop-helix dioxin receptor. In: Baeuerle P.A. (Ed). Inducible gene expression (1995), Birkhäuser, Boston p. 177-205
35. Gu Y.Z., Hogenesch J.B., and Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40 (2000) 519-561
36. Furness S.G., Lees M.J., and Whitelaw M.L. The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH/PAS transcription factors. FEBS Lett 581 (2007) 3616-3625
37. Puga A., Tomlinson C.R., and Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol 69 (2005) 199-207
38. Fritsche E., Schäfer C., Calles C., Bernsmann T., Bernshausen T., Wurm M., et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 104 (2007) 8851-8856
39. Beischlag T.V., Luis Morales J., Hollingshead B.D., and Perdew G.H. The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18 (2008) 207-250
40. Abbott B.D., Birnbaum L.S., and Perdew G.H. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev Dyn 204 (1995) 133-143
41. Crews S.T. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev (1998) 12607-12620
42. Campbell S.J., Henderson C.J., Anthony D.C., Davidson D., Clark A.J., and Wolf C.R. The murine Cyp1a1 gene is expressed in a restricted spatial and temporal pattern during embryonic development. J Biol Chem 280 (2005) 5828-5835
43. Omiecinski C.J., Redlich C.A., and Costa P. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res 50 (1990) 4315-4321
44. Choudhary D., Jansson I., Schenkman J.B., Sarfarazi M., and Stoilov I. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414 (2003) 91-100
45. Marlowe J.L., and Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96 (2005) 1174-1184
46. Weiss C., Faust D., Schreck I., Ruff A., Farwerck T., Melenberg A., et al. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 27 (2008) 2198-2207
47. Falahatpisheh M.H., and Ramos K.S. Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing. Oncogene 22 (2003) 2160-2171
48. McMillan B.J., and Bradfield C.A. The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol Pharmacol 72 (2007) 487-498
49. Nebert D.W., and Karp C.L. Endogenous functions of the Aryl hydrocarbon receptor: intersection of cytochrome P450 (CYP1)-metabolized eicosanoids and AHR biology. J Biol Chem August 18 (2008). http://www.jbc.org/cgi/doi/10.1074/jbc.R800053200 [Epub ahead of print]
50. Valdez K.E., and Petroff B.K. Potential roles of the aryl hydrocarbon receptor in female reproductive senescence. Reprod Biol 4 (2004) 243-258
51. Mukai M., Lin T.M., Peterson R.E., Cooke P.S., and Tischkau S.A. Behavioral rhythmicity of mice lacking AhR and attenuation of light-induced phase shift by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Rhythms 23 (2008) 200-210
52. Bunger M.K., Moran S.M., Glover E., Thomae T.L., Lahvis G.P., Lin B.C., et al. Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J Biol Chem 278 (2003) 17767-17774
53. Ikuta T., Tachibana T., Watanabe J., Yoshida M., Yoneda Y., and Kawajiri K. Nucleocytoplasmic shuttling of the aryl hydrocarbon receptor. J Biochem 127 (2000) 503-509
54. Pollenz R.S., Sattler C.A., and Poland A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 45 (1994) 428-438
55. Singh S.S., Hord N.G., and Perdew G.H. Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. Arch Biochem Biophys 329 (1996) 47-55
56. Enan E., and Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 52 (1996) 1599-1612
57. Petrulis J.R., Hord N.G., and Perdew G.H. Subcellular localization of the aryl hydrocarbon receptor is modulated by the immunophilin homolog hepatitis B virus X-associated protein 2. J Biol Chem 275 (2000) 37448-37453
58. Berg P., and Pongratz I. Two parallel pathways mediate cytoplasmic localization of the dioxin (aryl hydrocarbon) receptor. J Biol Chem 277 (2002) 32310-32319
59. Blankenship A., and Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced activation of a protein tyrosine kinase, pp60src, in murine hepatic cytosol using a cell-free system. Mol Pharmacol 52 (1997) 667-675
60. Ikuta T., Eguchi H., Tachibana T., Yoneda Y., and Kawajiri K. Nuclear localization and export signals of the human aryl hydrocarbon receptor. J Biol Chem 273 (1998) 2895-2904
61. Ikuta T., Kobayashi Y., and Kawajiri K. Phosphorylation of nuclear localization signal inhibits the ligand-dependent nuclear import of aryl hydrocarbon receptor. Biochem Biophys Res Commun 317 (2004 30) 545-550
62. Ikuta T., Watanabe J., and Kawajiri K. Characterization of the LxxLL motif in the aryl hydrocarbon receptor: effects on subcellular localization and transcriptional activity. J Biochem 131 (2002) 79-85
63. Reyes H., Reisz-Porszasz S., and Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256 (1992) 1193-1195
64. Nebert D.W., Puga A., and Vasiliou V. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann N Y Acad Sci 685 (1993) 624-640
65. Schrenk D. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem Pharmacol 55 (1998) 1155-1162
66. Birnbaum L.S. The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect 102 Suppl. 9 (1994) 157-167
67. Song Z., and Pollenz R.S. Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation, and gene regulation. Mol Pharmacol 62 (2002) 806-816
68. Santiago-Josefat B., Pozo-Guisado E., Mulero-Navarro S., and Fernandez-Salguero P.M. Proteasome inhibition induces nuclear translocation and transcriptional activation of the dioxin receptor in mouse embryo primary fibroblasts in the absence of xenobiotics. Mol Cell Biol 21 (2001) 1700-1709
69. Pollenz R.S., and Barbour E.R. Analysis of the complex relationship between nuclear export and aryl hydrocarbon receptor-mediated gene regulation. Mol Cell Biol 20 (2000) 6095-6104
70. Richter C.A., Tillitt D.E., and Hannink M. Regulation of subcellular localization of the aryl hydrocarbon receptor (AhR). Arch Biochem Biophys 389 (2001) 207-217
71. Zhang F., Hu Y., Huang P., Toleman C.A., Paterson A.J., and Kudlow J.E. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 282 (2007) 22460-22471
72. Hoang T., Fenne I.S., Cook C., Børud B., Bakke M., Lien E.A., et al. cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. J Biol Chem 279 (2004) 49120-49130
73. Chang C.Y., and Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 18 (1998) 525-535
74. Ikuta T., Kobayashi Y., and Kawajiri K. Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem 279 (2004) 19209-19216
75. Sadek C.M., and Allen-Hoffmann B.L. Suspension-mediated induction of Hepa 1c1c7 Cyp1a-1 expression is dependent on the Ah receptor signal transduction pathway. J Biol Chem 269 (1994) 31505-31509
76. Monk S.A., Denison M.S., and Rice R.H. Transient expression of CYP1A1 in rat epithelial cells cultured in suspension. Arch Biochem Biophys 393 1 (2001 Sep 1) 154-162
77. Ramadoss P., and Perdew G.H. The transactivation domain of the Ah receptor is a key determinant of cellular localization and ligand-independent nucleocytoplasmic shuttling properties. Biochemistry 44 (2005) 11148-11159
78. Shenolikar S. Protein phosphorylation: hormones, drugs, and bioregulation. FASEB J 2 (1988) 2753-2764
79. Heinrich R., and Kraiem Z. The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles. J Clin Endocrinol Metab 82 (1997) 1839-1844
80. Machemer D.E., and Tukey R.H. The role of protein kinase C in regulation of TCDD-mediated CYP1A1 gene expression. Toxicol Sci 8 (2005) 27-37
81. Berghard A., Gradin K., Pongratz I., Whitelaw M., and Poellinger L. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol Cell Biol 13 (1993) 677-689
82. Carrier F., Owens R.A., Nebert D.W., and Puga A. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol Cell Biol 12 (1992) 1856-1863
83. Mahon M.J., and Gasiewicz T.A. Ah receptor phosphorylation: localization of phosphorylation sites to the C-terminal half of the protein. Arch Biochem Biophys 318 (1995) 166-174
84. Chen Y.H., and Tukey R.H. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J Biol Chem 271 (1996) 26261-26266
85. Long W.P., Pray-Grant M., Tsai J.C., and Perdew G.H. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol Pharmacol 53 (1998) 691-700
86. Schafer M.W., Madhukar B.V., Swanson H.I., Tullis K., and Denison M.S. Protein kinase C is not involved in Ah receptor transformation and DNA binding. Arch Biochem Biophys 307 (1993) 267-271
87. Park S., Henry E.C., and Gasiewicz T.A. Regulation of DNA binding activity of the ligand-activated aryl hydrocarbon receptor by tyrosine phosphorylation. Arch Biochem Biophys 381 (2000) 302-312
88. Minsavage G.D., Park S.K., and Gasiewicz T.A. The aryl hydrocarbon receptor (AhR) tyrosine 9, a residue that is essential for AhR DNA binding activity, is not a phosphoresidue but augments AhR phosphorylation. J Biol Chem 279 (2004) 20582-20593
89. Bombick D.W., and Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60c-src. J Biochem Toxicol 2 (1987) 141-154
90. Lesca P., Peryt B., Larrieu G., Alvinerie M., Galtier P., Daujat M., et al. Evidence for the ligand-independent activation of the AH receptor. Biochem Biophys Res Commun 17 209 (1995) 474-482
91. Dzeletovic N., McGuire J., Daujat M., Tholander J., Ema M., Fujii-Kuriyama Y., et al. Regulation of dioxin receptor function by omeprazole. J Biol Chem 272 (1997) 12705-12713
92. Backlund M., and Ingelman-Sundberg M. Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases. Cell Signal 17 (2005) 39-48
93. Sasamori E., Shimoyama S., Fukushige S., and Kikuchi H. Involvement of CREM in CYP1A1 induction through ligand-independent activation pathway of aryl hydrocarbon receptor in HepG2 cells. Arch Biochem Biophys 478 (2008) 26-35
94. Dull A.B., Carlson D.B., Petrulis J.R., and Perdew G.H. Characterization of the phosphorylation status of the hepatitis B virus X-associated protein 2. Arch Biochem Biophys 406 (2002) 209-221
95. Ogiso H., Kagi N., Matsumoto E., Nishimoto M., Arai R., Shirouzu M., et al. Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. Biochemistry 43 (2004) 15510-15519
96. Huang H.C., Yu J.S., Tsay C.C., Lin J.H., Huang S.Y., Fang W.T., et al. Purification and characterization of porcine testis 90-kDa heat shock protein (HSP90) as a substrate for various protein kinases. J Protein Chem 21 2 (2002 Feb) 111-121
97. Hardie D.G. Biochemical messenger (1991), University Press, Cambridge
98. Enan E., Lasley B., Stewart D., Overstreet J., and Vandevoort C.A. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) modulates function of human luteinizing granulosa cells via cAMP signaling and early reduction of glucose transporting activity. Reprod Toxicol 10 (1996) 191-198
99. Vogel C.F., Sciullo E., Park S., Liedtke C., Trautwein C., and Matsumura F. Dioxin increases C/EBPbeta transcription by activating cAMP/protein kinase A. J Biol Chem 279 (2004) 8886-8894
100. Lavery D.J., Lopez-Molina L., Margueron R., Fleury-Olela F., Conquet F., Schibler U., et al. Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP. Mol Cell Biol 19 (1999) 6488-6499
101. Viitala P., Posti K., Lindfors A., Pelkonen O., and Raunio H. cAMP mediated upregulation of CYP2A5 in mouse hepatocytes. Biochem Biophys Res Commun 280 (2001) 761-767
102. Phillips M., Enan E., Liu P.C., and Matsumura F. Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Cell Sci 108 (1995) 395-402
103. Takanaga H., Kunimoto M., Adachi T., Tohyama C., and Aoki Y. Inhibitory effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on cAMP-induced differentiation of rat C6 glial cell line. J Neurosci Res 64 (2001) 402-409
104. Enan E., Moran F., VandeVoort C.A., Stewart D.R., Overstreet J.W., and Lasley B.L. Mechanism of toxic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in cultured human luteinized granulosa cells. Reprod Toxicol 10 (1996) 497-508
105. Fitzgerald C.T., Fernandez-Salguero P., Gonzalez F.J., Nebert D.W., and Puga A. Differential regulation of mouse Ah receptor gene expression in cell lines of different tissue origins. Arch Biochem Biophys 333 (1996) 170-178
106. Galperin M.Y. Bacterial signal transduction network in a genomic perspective. Environ Microbiol 6 (2004) 552-567
107. Carlson D.B., and Perdew G.H. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 16 (2002) 317-325
108. Zheng W., Brake P.B., Bhattacharyya K.K., Zhang L., Zhao D., and Jefcoate C.R. Cell selective cAMP induction of rat CYP1B1 in adrenal and testis cells. Identification of a novel cAMP-responsive far upstream enhancer and a second Ah receptor-dependent mechanism. Arch Biochem Biophys 416 (2003) 53-67
109. Sun H., Xu B., Inoue H., and Chen Q.M. p38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes. Cell Signal 20 (2008) 1952-1959
110. Vogel C., Schuhmacher U.S., Degen G.H., Bolt H.M., Pineau T., and Abel J. Modulation of prostaglandin H synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Arch Biochem Biophys 351 (1998) 265-271
111. Landers J.P., and Bunce N.J. The Ah receptor and the mechanism of dioxin toxicity. Biochem J 276 (1991) 273-287
112. Choi S.S., Miller M.A., and Harper P.A. In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin induces amphiregulin gene expression in the developing mouse ureter. Toxicol Sci 94 (2006) 163-174
113. Wayne C.M., Fan H.Y., Cheng X., and Richards J.S. Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol 21 (2007) 1940-1957
114. Oesch-Bartlomowicz B., Huelster A., Wiss O., Antoniou-Lipfert P., Dietrich C., Arand M., et al. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proc Natl Acad Sci U S A 102 (2005) 9218-9223
115. Nemoto N., and Sakurai J. Differences in regulation of gene expression between Cyp1a-1 and Cyp1a-2 in adult mouse hepatocytes in primary culture. Carcinogenesis 13 (1992) 2249-2254
116. Zhang Q.Y., He W., Dunbar D., and Kaminsky L. Induction of CYP1A1 by beta-naphthoflavone in IEC-18 rat intestinal epithelial cells and potentiation of induction by dibutyryl cAMP. Biochem Biophys Res Commun 233 (1997) 623-626
117. Xiao G., Falkner K.C., Xie Y., Lindahl R.G., and Prough R.A. cAMP-dependent negative regulation of rat aldehyde dehydrogenase class 3 gene expression. J Biol Chem 272 (1997) 3238-3245
118. Heckert L.L. Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase a and requires upstream stimulatory factor binding to a proximal E box element. Mol Endocrinol 15 (2001) 704-715
119. Takahashi Y., Nakayama K., Itoh S., Fujii-Kuriyama Y., and Kamataki T. Inhibition of the transcription of CYP1A1 gene by the upstream stimulatory factor 1 in rabbits. Competitive binding of USF1 with AhR. Arnt complex. J Biol Chem 272 (1997) 30025-30031
120. Pawson T., and Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science 278 (1997) 2075-2080
121. Cooper D.M. Compartmentalization of adenylate cyclase and cAMP signalling. Biochem Soc Trans 33 (2005) 1319-1322
122. Zippin J.H., Farrell J., Huron D., Kamenetsky M., Hess K.C., Fischman D.A., et al. Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB J 17 (2003) 82-84
123. Steinberg R.A., Cauthron R.D., Symcox M.M., and Shuntoh H. Autoactivation of catalytic (C alpha) subunit of cyclic AMP-dependent protein kinase by phosphorylation of threonine 197. Mol Cell Biol 13 (1993) 2332-2341
124. Adams J.A., McGlone M.L., Gibson R., and Taylor S.S. Phosphorylation modulates catalytic function and regulation in the cAMP-dependent protein kinase. Biochemistry 34 (1995) 2447-2454
125. Wong W., and Scott J.D. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5 (2004) 959-970
126. Willoughby D., and Cooper D.M. Live-cell imaging of cAMP dynamics. Nat Methods 5 (2008) 29-36
127. Mei F.C., Qiao J., Tsygankova O.M., Meinkoth J.L., Quilliam L.A., and Cheng X. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 277 (2002) 11497-11504
128. Hochbaum D., Hong K., Barila G., Ribeiro-Neto F., and Altschuler D.L. Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis. J Biol Chem (2008) 2834464-2834468
129. Willoughby D., Wong W., Schaack J., Scott J.D., and Cooper D.M. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J (2006) 252051-252061
130. Houslay M.D., and Adams D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370 (2003) 1-18
131. Lynch M.J., Baillie G.S., and Houslay M.D. cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm for understanding the unique non-redundant roles that PDE4 isoforms play in shaping compartmentalized cAMP cell signalling. Biochem Soc Trans (2007) 35938-35941
132. Dodge K.L., Khouangsathiene S., Kapiloff M.S., Mouton R., Hill E.V., Houslay M.D., et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J (2001) 201921-201930
133. Pawson T., and Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 300 (2003) 445-452
134. Anantharaman V., Koonin E.V., and Aravind L. Regulatory potential, phyletic distribution and evolution of ancient, intracellular small-molecule-binding domains. J Mol Biol 307 (2001) 1271-1292
135. Martinez S.E., Beavo J.A., and Hol W.G. GAF domains: two-billion-year-old molecular switches that bind cyclic nucleotides. Mol Interv 2 (2002) 317-323
136. Gilles-Gonzalez M.A., and Gonzalez G. Signal transduction by heme-containing PAS-domain proteins. J Appl Physiol 96 (2004) 774-783
137. Gross-Langenhoff M., Hofbauer K., Weber J., Schultz A., and Schultz J.E. cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11. J Biol Chem 281 (2006) 2841-2846
138. Bartlomowicz B., Waxman D., Utesch D., Oesch F., and Friedberg T. Phosphorylation of carcinogen metabolizing enzymes: regulation of the phosphorylation status of the major phenobarbital inducible cytochromes P-450 in hepatocytes. Carcinogenesis 10 (1989) 225-228
139. Bartlomowicz B., Friedberg T., Utesch D., Molitor E., Platt K.L., and Oesch F. Regio- and stereoselective regulation of monooxygenase activities by isoenzyme-selective phosphorylation of cytochrome P450. Biochem Biophys Res Commun 160 (1989) 46-52
140. Oesch-Bartlomowicz B., Arens H.J., Richter B., Hengstler J.G., and Oesch F. Control of the mutagenicity of aromatic amines by protein kinases and phosphatases. I. The protein phosphatase inhibitors okadaic acid and ortho-vanadate drastically reduce the mutagenicity of aromatic amines. Arch Toxicol 71 (1997) 601-611
141. Oesch-Bartlomowicz B., and Oesch F. Phosphorylation of cytochrome P450: First discovery of a posttranslational modification of a drug metabolizing enzyme. Biochem Biophys Res Commun 338 (2005) 446-449
142. Oesch-Bartlomowicz B., Padma P.R., Becker R., Richter B., Hengstler J.G., Freeman J.E., et al. Differential modulation of CYP2E1 activity by cAMP dependent protein kinase upon Ser129 replacement. Exp Cell Res 242 (1998) 294-302
143. Oesch-Bartlomowicz B., and Oesch F. Cytochrome-P450 phosphorylation as a functional switch. Arch Biochem Biophys 409 (2003) 228-234
144. Oesch-Bartlomowicz B., Vogel S., Arens H.J., and Oesch F. Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A. Mutat Res 232 (1990) 305-312
145. Mimura J., Ema M., Sogawa K., and Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 13 (1999) 20-25
146. Evans B.R., Karchner S.I., Allan L.L., Pollenz R.S., Tanguay R.L., Jenny M.J., et al. Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator. Mol Pharmacol 73 (2008) 387-398
147. de Oliveira S.K., Hoffmeister M., Gambaryan S., Müller-Esterl W., Guimaraes J.A., and Smolenski A.P. Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. J Biol Chem 282 (2007) 13656-13663
148. Vogel C.F., Sciullo E., Li W., Wong P., Lazennec G., and Matsumura F. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 21 (2007) 2941-2955
149. Bolger G.B., Peden A.H., Steele M.R., MacKenzie C., McEwan D.G., and Wallace D.A. Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem 278 (2003) 33351-33363
150. Vandromme M., Carnac G., Gauthier-Rouvière C., Fesquet D., Lamb N., and Fernandez A. Nuclear import of the myogenic factor MyoD requires cAMP-dependent protein kinase activity but not the direct phosphorylation of MyoD. J Cell Sci 107 (1994) 613-620
151. Mosialos G., Hamer P., Capobianco A.J., Laursen R.A., and Gilmore T.D. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Mol Cell Biol 11 (1991) 5867-5877
152. Michel J.J., and Scott J.D. AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol 42 (2002) 235-257
153. Taskén K., and Aandahl E.M. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84 (2004) 137-167
154. Zaccolo M., De Giorgi F., Cho C.Y., Feng L., Knapp T., Negulescu P.A., et al. A genetically encoded, fluorescent indicator for cyclic AMP in living cells. Nat Cell Biol 2 (2000) 25-29
155. Mongillo M., McSorley T., Evellin S., Sood A., Lissandron V., Terrin A., et al. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ Res 95 (2004) 67-75
156. Nikolaev V.O., Bünemann M., Hein L., Hannawacker A., and Lohse M.J. Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279 (2004) 37215-37218